FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Viswanath Devanarayan

Research Profile

Chemicals & Drugs

Procedures

Concepts & Ideas

Occupations

Physiology

Devices

Oligonucleotide Array Sequence Analysis

Disorders

Alzheimer's Disease

Activities & Behaviors

Co-author Network

Publications

TOP 3
Daniel Adolfo Llano; Jeffrey F Waring; David G Witte; Viswanath Devanarayan; Teresa Ellis; Jinhe Li; Robert A Lenz
Cerebrospinal fluid cytokine dynamics differ between Alzheimer disease patients and elderly controls.
Eric R Goedken; Christopher M Harris; James P Jakway; David C Jordan; Viswanath Devanarayan; Lori A Dowding; Jeffrey W Voss; Neil Wishart; Robert Talanian
Minimum significant ratio of selectivity ratios (MSRSR) and confidence in ratio of selectivity ratios (CRSR): quantitative measures for selectivity ratios obtained by screening assays.
Ke Zhang; Youping Deng; Viswanath Devanarayan; Linglin Xie; Yi Yang; Sens Donald
A hidden Markov model-based algorithm for identifying tumour subtype using array CGH data.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Viswanath Devanarayan (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Daniel Adolfo Llano; Jeffrey F Waring; David G Witte; Viswanath Devanarayan; Teresa Ellis; Jinhe Li; Robert A Lenz
Cerebrospinal fluid cytokine dynamics differ between Alzheimer disease patients and elderly controls.
Alzheimer disease and associated disorders 2012;26(4):322-8.
2012: Eric R Goedken; Christopher M Harris; James P Jakway; David C Jordan; Viswanath Devanarayan; Lori A Dowding; Jeffrey W Voss; Neil Wishart; Robert Talanian
Minimum significant ratio of selectivity ratios (MSRSR) and confidence in ratio of selectivity ratios (CRSR): quantitative measures for selectivity ratios obtained by screening assays.
Journal of biomolecular screening 2012;17(7):857-67.
2011: Ke Zhang; Youping Deng; Viswanath Devanarayan; Linglin Xie; Yi Yang; Sens Donald
A hidden Markov model-based algorithm for identifying tumour subtype using array CGH data.
BMC genomics 2011;12 Suppl 5():S10.
2011: Shalini Gupta; Viswanath Devanarayan; Deborah Finco; George R Gunn; Susan Kirshner; Susan Richards; Bonita Rup; An Song; Meena Subramanyam
Recommendations for the validation of cell-based assays used for the detection of neutralizing antibody immune responses elicited against biological therapeutics.
Journal of pharmaceutical and biomedical analysis 2011;55(5):878-88.
2011: Daniel Adolfo Llano; Genevieve Laforet; Viswanath Devanarayan
Derivation of a new ADAS-cog composite using tree-based multivariate analysis: prediction of conversion from mild cognitive impairment to Alzheimer disease.
Alzheimer disease and associated disorders 2011;25(1):73-84.
2010: Stephen K Tahir; John Wass; Mary K Joseph; Viswanath Devanarayan; Paul Hessler; Haichao Zhang; Steven W Elmore; Paul E Kroeger; Christin Tse; Saul H Rosenberg; Mark G Anderson
Identification of expression signatures predictive of sensitivity to the Bcl-2 family member inhibitor ABT-263 in small cell lung carcinoma and leukemia/lymphoma cell lines.
Molecular cancer therapeutics 2010;9(3):545-57.
2010: Viswanath Devanarayan; Mary-Beth Scholand; John Hoidal; Mark F Leppert; Michael A Crackower; Gary P O'Neill; Francois G Gervais
Identification of distinct plasma biomarker signatures in patients with rapid and slow declining forms of COPD.
COPD 2010;7(1):51-8.
2008: Gopi Shankar; Viswanath Devanarayan; Lakshmi Amaravadi; Yu Chen Barrett; Ronald Bowsher; Deborah Finco-Kent; Michele Fiscella; boris gorovits; Susan Kirschner; Michael Moxness; Thomas Parish; Valerie Quarmby; Holly Smith; Wendell Smith; Linda A Zuckerman; Eugen Koren
Recommendations for the validation of immunoassays used for detection of host antibodies against biotechnology products.
Journal of pharmaceutical and biomedical analysis 2008;48(5):1267-81.
2008: Guoxin Wu; Sethu Sankaranarayanan; Kate Tugusheva; Jason Kahana; Guy Seabrook; Xiao-Ping Shi; Elizabeth King; Viswanath Devanarayan; Jacquelynn J Cook; Adam J Simon
Decrease in age-adjusted cerebrospinal fluid beta-secretase activity in Alzheimer's subjects.
Clinical biochemistry 2008;41(12):986-96.
2008: Eugen Koren; Holly W Smith; Elizabeth Shores; Gopi Shankar; Deborah Finco-Kent; Bonita Rup; Yu Chen Barrett; Viswanath Devanarayan; boris gorovits; Shalini Gupta; Thomas Parish; Valerie Quarmby; Michael Moxness; Steven J Swanson; Gary Taniguchi; Linda A Zuckerman; Christopher C Stebbins; Anthony Mire-Sluis
Recommendations on risk-based strategies for detection and characterization of antibodies against biotechnology products.
Journal of immunological methods 2008;333(1-2):1-9.
2007: Mario L Rocci; Viswanath Devanarayan; David B Haughey; Paula Jardieu
Confirmatory reanalysis of incurred bioanalytical samples.
The AAPS journal 2007;9(3):E336-43.
2006: James R Henry; Yihong Li; Alan M Warshawsky; Joseph T Brozinick; Eric D Hawkins; Elizabeth A Misener; Daniel A Briere; Chahrzad Montrose-Rafizadeh; Richard W Zink; Nathan Yumibe; Rose T Ajamie; Brad Wilken; Viswanath Devanarayan
Tetrahydroisoquinoline PPARgamma agonists: design of novel, highly selective non-TZD antihyperglycemic agents.
Bioorganic & medicinal chemistry letters 2006;16(24):6293-7.
2006: Chad A Ray; Carmen Dumaual; Mark B Willey; Jeffrey Fill; Peter J O'Brien; Ian Gourley; Viswanath Devanarayan; Robert J Konrad
Optimization of analytical and pre-analytical variables associated with an ex vivo cytokine secretion assay.
Journal of pharmaceutical and biomedical analysis 2006;41(1):189-95.
2006: Jean W Lee; Viswanath Devanarayan; Yu Chen Barrett; Russell Weiner; John Allinson; Scott Fountain; Stephen Keller; Ira Weinryb; Marie Green; Larry Duan; James A Rogers; Robert Millham; Peter J O'Brien; Jeffrey Sailstad; Masood N Khan; Chad Ray; John A Wagner
Fit-for-purpose method development and validation for successful biomarker measurement.
Pharmaceutical research 2006;23(2):312-28.
2005: Chad A Ray; Ronald R Bowsher; Wendell C Smith; Viswanath Devanarayan; Mark B Willey; John T Brandt; Robert A Dean
Development, validation, and implementation of a multiplex immunoassay for the simultaneous determination of five cytokines in human serum.
Journal of pharmaceutical and biomedical analysis 2005;36(5):1037-44.
2004: Anthony Mire-Sluis; Yu Chen Barrett; Viswanath Devanarayan; Eugene Koren; Hank Liu; Mauricio Maia; Thomas Parish; George Scott; Gopi Shankar; Elizabeth Shores; Steven J Swanson; Gary Taniguchi; Daniel Wierda; Linda A Zuckerman
Recommendations for the design and optimization of immunoassays used in the detection of host antibodies against biotechnology products.
Journal of immunological methods 2004;289(1-2):1-16.
2003: Janardhan Sampath; Pandy R Long; Robert L Shepard; Xiaoling Xia; Viswanath Devanarayan; George E Sandusky; William L Perry; Anne H Dantzig; Mark Williamson; Mark Rolfe; Richard E Moore
Human SPF45, a splicing factor, has limited expression in normal tissues, is overexpressed in many tumors, and can confer a multidrug-resistant phenotype to cells.
The American journal of pathology 2003;163(5):1781-90.
2002: Yi Hu; Andrew G Stephen; Jin Cao; LEE TANZER; Christopher A Slapak; Steadman D Harrison; Viswanath Devanarayan; Anne H Dantzig; James J Starling; Leonard H Rome; Richard E Moore
A very early induction of major vault protein accompanied by increased drug resistance in U-937 cells.
International journal of cancer. Journal international du cancer 2002;97(2):149-56.
2000: D Stanislaus; Viswanath Devanarayan; Janet Hock
In vivo comparison of activated protein-1 gene activation in response to human parathyroid hormone (hPTH)(1-34) and hPTH(1-84) in the distal femur metaphyses of young mice.
Bone 2000;27(6):819-26.